CLINICAL_TRIALS
trial_result
· 2019-05-08
Clinical Trial Update: Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial [Phase 2]
Summary
Phase 2 trial investigating aprepitant for relief of nausea in patients with gastroparesis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-08